Printer Friendly

Articles from M2 Pharma (August 24, 2017)

1-33 out of 33 article(s)
Title Author Type Words
Astellas doses first patient in Phase 3 MORPHO trial of gilteritinib. 234
BioMarin reports exercise of underwriters option to purchase up to an additional USD45m senior notes. 132
Boehringer Ingelheim launches phase one clinical trials to evaluate glucagon/GLP-1 agonist and an amylin analogue. 251
Bonti Initiates LANTERN-1 Study Evaluating EB-001 in Reducing Musculoskeletal Pain. 231
Cel-Sci Raises USD 3.5m in Common Stock Offering. 262
Channel Medsystems awarded USD14.1m financing for office-based treatment of heavy menstrual bleeding. 255
DarioHealth concludes USD5m private placement offerings. 183
Deputy Launches New Suite of Healthcare Features. 387
Epygenix Therapeutics wins US FDA's orphan drug designation for EPX-300 for treating catastrophic form of epilepsy Dravet Syndrome. 247
FDA Grants Epygenix Therapeutics Orphan Drug Designation for EPX-300 for Treatment of Dravet Syndrome. 227
Fuentes Named EVP, Research at Blade Therapeutics. 354
GHP Specialty Care names Erik Wassberg as new CEO of SKMCA hospital in UAE. 144
Grid Therapeutics signs license agreement with Duke University. 121
Iconic Therapeutics Names Brandon Smith as COO. 222
Jounce Therapeutics names new chief business officer and head of corporate development. 196
Lithium in tap water linked to reduction in likelihood of dementia. 562
Medizone International discloses planned resignation of board director Dwayne Montgomery. 148
MMJ Labs wins US patent for Cool-Pulse Technology to combat pain. 185
NAGASE expands US specialty chemicals footprints through acquisition of Fitz Chem. 234
Newly-Formed Biotech Celularity Completes Series A Financing. 276
Novartis receives EU approval of Kisqali. 243
Omeros Closes USD 68.3m Stock Offering. 319
Otsuka and Mylan agree licence deal for tuberculosis treatment. 276
Otsuka signs license agreement for delamanid for treating pulmonary multidrug-resistant tuberculosis in low- and middle-income countries. 333
PharmaLex names new senior director, regulatory affairs and service area. 172
Quality Systems Appoints Klapstein to Board of Directors. 205
SQZ Biotech names Shefali Agarwal MD, MPH as CMO. 162
Takeda submits New Drug Application in Japan for ulcerative colitis treatment. 228
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. 231
University of Birmingham repurposing diabetes drug for brain pressure. 273
Unum Therapeutics to Initiate Trial of ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma in 1Q18. 354
ViraCyte reveals positive data from Phase two clinical trial of Viralym-M. 188
ZeOmega Platform Retains NCQA Certification for the Management of 10 Chronic Diseases. Disease/Disorder overview 269

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters